Key players profiled in this report are: Sartorius AG, Thermo Fisher Scientific, Inc. The main engineering, procurement and construction (EPC) included in this report are Amec, Merck KGaA , GE Healthcare), Danaher Corporation, Eppendorf AG Foster Wheeler plc, Fluor Corporation, Jacobs Engineering Group Inc., M + W Group, PM Groupand Tech Tip
Houston, TX -- (SBWIRE) -- 04/03/2018 -- Increased adoption of single-use technology, the use of hybrid technology: single use and stainless steel, factors such as the increase in the popularity of disposable bioreactors among bio-pharmaceutical companies and the increase in biological products to promote the growth of the global bioreactor market. In addition, government support to create innovative bio-economies has stimulated R & D activities, increased the incidence of lifestyle-related diseases such as diabetes and cancer, and has made the government an attractive place to invest in North America.
The key factor responsible for this high demand is the increased consumer demand for bio pharmaceuticals by consumers. Since bio-pharmaceuticals modulate physiological processes at the cellular level, they are effective in the treatment of disorders that are difficult to be treated by conventional pharmaceuticals. Bio-pharmaceuticals are currently experiencing high growth led by improved healthcare awareness, demand in developing regions, development of novel therapies such as cancer treatment, and ongoing research in developing new technology products in biotechnology and healthcare. Global bioreactor market is expected to flourish at a CAGR of 6.9% during the forecast period.
For Sample Copy of this report: https://www.researchnreports.com/request_sample.php?id=62409
The bioreactor market is also dominated by single-use bioreactors that account for a large part of their overall use in various applications. Low upfront investment cost is the key factor that is responsible for higher usage of single-use bioreactors over fixed systems. By lowering the costs of cleaning and sterilizing bioreactors and additionally enhancing the flexibility in operations during drug manufacturing process, the adoption of single-use bioreactors results in reduced capital expenditure costs.
This report considers mainly three types of bioreactor materials: glass, stainless steel, and disposable bioreactors. Glass bioreactors are mainly used for R & D and process development. They are also used in academic and research institutions. The disposable segment accounted for approximately 45% of the worldwide bioreactor market in 2018. Much of this sector is due to the widespread use of single-use bioreactors throughout clinical and commercial production.
Avail Discount on this report : https://www.researchnreports.com/ask_for_discount.php?id=62409
In this report, the bioreactor market is divided into four major sectors: North America, Europe, Asia Pacific and other regions. By region, North America accounted for 40% of the total bioreactor market. Asia-Pacific countries are expected to see the highest growth in the bioreactor market due to the expansion of biopharmaceuticals in the region. For example, China is the preferred destination for biopharmaceutical companies leading biopharmaceutical production,
The global bioreactor market is categorized by end user, usage, scale, materials, management type and vendor. Geographic analysis also targets North America, Europe, Asia Pacific and other regions (RoW).
Based on end users, the bioreactor market is divided into R & D divisions and bio-pharmaceutical companies. The R & D department is expected to record the highest growth rate from 2018 to 2023, with increased use of bioreactors in process development. On the other hand, contract manufacturing organizations (CMOs) are expected to increase their demand as biologics manufacturers' outsourcing demand increases due to increased demand for biologics.
For more information : https://www.researchnreports.com/enquiry_before_buying.php?id=62409
By material, disposable bioreactors are expected to show the second highest growth in volume in the forecast period from 2017 to 2022. The high growth of this sector is due to the advantages of SUB such as reduced need for cleaning and sanitizing, A more powerful agent for pollution and aseptic conditions
The study aims to identify new trends and opportunities in the global bioreactor market, along with a breakdown of sales breakdowns. Provide a comprehensive competitive landscape and identify key players in relation to share-sharing. The research also includes a detailed classification of the global bioreactor market based on end users, usage, size, materials, type of management and suppliers.
The major OEM / system vendors included in this report are Sartorius AG (Germany), Thermo Fisher Scientific, Inc. The main engineering, procurement and construction (EPC) athletes included in this report are Amec (Germany), Merck KGaA (Germany), GE Healthcare (a subsidiary of General Electric Company, USA), Danaher Corporation, Eppendorf AG Foster Wheeler plc (UK), Fluor Corporation (USA), Jacobs Engineering Group Inc. (USA), M + W Group (Germany), PM Group (Ireland) and Tech Tip SA (France)